B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

9.150 -0.130 (-1.40%)
Streaming Delayed Price Updated: 9:38 AM EDT, Apr 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ADMA Biologics Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Why Adma Biologics Was Trouncing the Market Today ↗
The company beat analyst estimates for both revenue and profitability, and raised revenue guidance. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Earnings Preview: ADMA Biologics ↗
 
Via Benzinga
News headline image
ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023
Conference Call Scheduled for November 8, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Preview: ADMA Biologics's Earnings ↗
 
Via Benzinga
News headline image
Recap: ADMA Biologics Q1 Earnings ↗
 
Via Benzinga
News headline image
A Preview Of ADMA Biologics's Earnings ↗
 
Via Benzinga
News headline image
Why Shares of ADMA Biologics Are Climbing Thursday ↗
The company, which focuses on infectious diseases, reported its second-quarter earnings on Wednesday after the markets closed. 
Via The Motley Fool
News headline image
ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
Conference Call Scheduled for August 9, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Earnings Outlook For ADMA Biologics ↗
 
Via Benzinga
News headline image
ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023
Conference Call Scheduled for May 10, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Amendment to Credit Agreement
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50. 
Via Benzinga
News headline image
ADMA Biologics, C3.ai And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded lower, with the Dow Jones dropping around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Dow Down 150 Points; US Durable Goods Orders Drop In February ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday. Following the market opening Friday, the Dow traded down 0.50% to 31,944.01 while the NASDAQ fell 0.52%... 
Via Benzinga
News headline image
Oxford Industries, Express And 3 Stocks To Watch Heading Into Friday ↗
With US futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
After-Hours Action: Why ADMA Biologics Shares Are Trading Higher ↗
ADMA Biologics Inc (NASDAQ: ADMA) shares are moving higher in extended trading Thursday after the commercial biopharmaceutical company reported  
Via Benzinga
News headline image
ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023
Conference Call Scheduled for March 23, 2023, at 4:30 p.m. ET 
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For March 23, 2023 ↗
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter. 
Via Benzinga
News headline image
7 A-Rated Penny Stocks Worth Betting On ↗
Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance. 
Via InvestorPlace
News headline image
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine ↗
Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio. 
Via InvestorPlace
News headline image
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance
From ADMA Biologics, Inc.
Via GlobeNewswire
News headline image
Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.